2-Deoxy-D-Glucose;2-deoxy-D-glucose, mixture of anomers;2-deoxy-D-glucose grade iii;2-deoxy-D-glucose grade ii;2-Deoxy-D-Arabino;2-DEOXY-D-ARABINOHEXOSE;2-Deoxy-D-glucose (2-DG,NSC 15193,Ba 2758);DEOXY-D-GLUCOSE, 2-(RG);2-deoxy-d-arabino-hexos;2-Deoxy-D-arabino-hexose;D-Arabino-2-deoxyhexose;p-DiMethylaMinobenzalrhodanine;2-Deoxyglucose;2-dg;ba2758;D-2dGlc;nsc15193;deoxyglucose;2-deoxy-glucos;D-2-GLUCODESOSE;d-2-deoxyglucose;2-deoxy-d-glucos;2-Deoxy-D-mannose;D-Arabino-hexose, 2-deoxy-;arabino-Hexose, 2-deoxy-;D-Glucose, 2-deoxy-;9G2MP84A8W;(3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal;2 Deoxyglucose;2 Deoxy D glucose;2 Desoxy D glucose;D-arabino-2-desoxyhexose;deoxy-d-glucose, 2-;2-DEOXYLGLUCOSE;2-INNo-D-AEIIC;KSC175S5P;Jsp003004;VRYA
Cas No.
154-17-6
分子式
C6H12O5
分子量
164.16
包装储存
Powder; -20°C; 3 years; 4°C; 2 years;
生物活性
2-Deoxy-D-glucose is a glucose analog that acts as a competitive inhibitor of glucose metabolism, inhibiting glycolysis via its actions on hexokinase.
性状
Solid
IC50 & Target[1][2]
HSV-1
体外研究(In Vitro)
2-Deoxy-D-glucose (2-DG, 4, 8, or 16 mM) significantly reduces the level of ATP in MCF-7 cells in a dose- and time-dependent manner that paralleles the effects of 2-DG on cell growth. The levels of phosphorylated Akt are significantly decreased, whereas the levels of phosphorylated AMPK and Sirt-1 are significantly increased in MCF-7 cells exposed to 2-Deoxy-D-glucose at 4, 8, or 16 mM for 1, 3, or 5 days in a dose- and time-dependent manner. 2-DG treatment increases the levels of pentose phosphate pathway (PPP) metabolites and augments the generation of NADPH by glucose-6-phosphate dehydrogenase. An increase in NADPH and upregulation of glutathione synthetase expression resultes in the increase in the reduced form of glutathione by 2-DG in NB4 cells.Medlife has not independently confirmed the accuracy of these methods. They a
体内研究(In Vivo)
2-Deoxy-D-glucose (0.03%, w/w) causes a 7% decrease in final weight that is statistically significant, and delayes the appearance of palpable mammary carcinomas. 2-Deoxy-D-glucose (3 mmol/kg, i.v.) is decreased in a dose-dependent manner in rat muscle.Medlife has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature or refrigerated transport.
储存方式
Powder; -20°C; 3 years; 4°C; 2 years;
ClinicalTrial
结构分类
SaccharidesMonos
溶解度数据
体外研究:H2O : ≥ 24 mg/mL(146.20 mM)*≥ means soluble, but saturation unknown. 配制储存液